PBS rules harming access to opioid addiction treatments, warns GP
Dr Paul Grinzi says vulnerable patients are paying $40 a week for the medications because of pharmacy dispensing costs
Uptake of opioid agonist therapies could be dramatically improved if they were no longer listed on the PBS as highly specialised drugs, says a leading GP working in the field.
The Federal Government is currently reviewing how methadone and buprenorphine treatments for opioid use disorders are funded through the PBS, saying it wants to address barriers to patient access.
